Showing results (311-320 of 387) with videos related to

Sort By:
Pageof 39
Antimicrobial Agents and Chemotherapy|June 13, 2018
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesJeong-Joong Yoon, Mart Toots, Sujin Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
<i>De novo</i> emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case reportShiv Gandhi, Jonathan Klein, Alexander Robertson, et al.
Scientific Reports|February 23, 2021
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Isabelle Q Phan, Sandhya Subramanian, David Kim, et al.
Communications Biology|January 15, 2025
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunitySaid Mougari, Valérie Favède, Camilla Predella, et al.
Emerging Infectious Diseases|October 24, 2024
Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019-2021Sarah N Cox, Amanda M Casto, Nicholas M Franko, et al.
Journal of Virology|January 26, 2022
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic MiceTing Y Wong, Alexander M Horspool, Brynnan P Russ, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency VirusScott L Letendre, Huichao Chen, Ashley McKhann, et al.
Cell Host & Microbe|July 20, 2024
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutininFrances C Welsh, Rachel T Eguia, Juhye M Lee, et al.
Pageof 39